Literature DB >> 29275860

Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.

Marvin H Gee1, Arnold Han2, Shane M Lofgren3, John F Beausang4, Juan L Mendoza5, Michael E Birnbaum1, Michael T Bethune6, Suzanne Fischer5, Xinbo Yang5, Raquel Gomez-Eerland7, David B Bingham8, Leah V Sibener1, Ricardo A Fernandes5, Andrew Velasco5, David Baltimore6, Ton N Schumacher7, Purvesh Khatri3, Stephen R Quake9, Mark M Davis10, K Christopher Garcia11.   

Abstract

The immune system can mount T cell responses against tumors; however, the antigen specificities of tumor-infiltrating lymphocytes (TILs) are not well understood. We used yeast-display libraries of peptide-human leukocyte antigen (pHLA) to screen for antigens of "orphan" T cell receptors (TCRs) expressed on TILs from human colorectal adenocarcinoma. Four TIL-derived TCRs exhibited strong selection for peptides presented in a highly diverse pHLA-A∗02:01 library. Three of the TIL TCRs were specific for non-mutated self-antigens, two of which were present in separate patient tumors, and shared specificity for a non-mutated self-antigen derived from U2AF2. These results show that the exposed recognition surface of MHC-bound peptides accessible to the TCR contains sufficient structural information to enable the reconstruction of sequences of peptide targets for pathogenic TCRs of unknown specificity. This finding underscores the surprising specificity of TCRs for their cognate antigens and enables the facile indentification of tumor antigens through unbiased screening.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cell; T cell receptor; antigens; cancer; combinatorial biology; human leukocyte antigen; ligand identification; peptide library; peptides; single-cell sequencing

Mesh:

Substances:

Year:  2017        PMID: 29275860      PMCID: PMC5786495          DOI: 10.1016/j.cell.2017.11.043

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  63 in total

1.  Identifying specificity groups in the T cell receptor repertoire.

Authors:  Jacob Glanville; Huang Huang; Allison Nau; Olivia Hatton; Lisa E Wagar; Florian Rubelt; Xuhuai Ji; Arnold Han; Sheri M Krams; Christina Pettus; Nikhil Haas; Cecilia S Lindestam Arlehamn; Alessandro Sette; Scott D Boyd; Thomas J Scriba; Olivia M Martinez; Mark M Davis
Journal:  Nature       Date:  2017-06-21       Impact factor: 49.962

2.  Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Authors:  Sebastian Kreiter; Mathias Vormehr; Niels van de Roemer; Mustafa Diken; Martin Löwer; Jan Diekmann; Sebastian Boegel; Barbara Schrörs; Fulvia Vascotto; John C Castle; Arbel D Tadmor; Stephen P Schoenberger; Christoph Huber; Özlem Türeci; Ugur Sahin
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

3.  Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain.

Authors:  Ted Hansen; Y Y Lawrence Yu; Daved H Fremont
Journal:  Curr Protoc Immunol       Date:  2009-11

4.  Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.

Authors:  T Sudo; N Kamikawaji; A Kimura; Y Date; C J Savoie; H Nakashima; E Furuichi; S Kuhara; T Sasazuki
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

5.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation.

Authors:  C A O'callaghan; M F Byford; J R Wyer; B E Willcox; B K Jakobsen; A J McMichael; J I Bell
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365

6.  Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization.

Authors:  Evan W Newell; Natalia Sigal; Nitya Nair; Brian A Kidd; Harry B Greenberg; Mark M Davis
Journal:  Nat Biotechnol       Date:  2013-06-09       Impact factor: 54.908

7.  TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.

Authors:  Oleg Y Borbulevych; Sujatha M Santhanagopolan; Moushumi Hossain; Brian M Baker
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

8.  Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.

Authors:  Timothy A Graubert; Dong Shen; Li Ding; Theresa Okeyo-Owuor; Cara L Lunn; Jin Shao; Kilannin Krysiak; Christopher C Harris; Daniel C Koboldt; David E Larson; Michael D McLellan; David J Dooling; Rachel M Abbott; Robert S Fulton; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Marcus Grillot; Jack Baty; Sharon Heath; John L Frater; Talat Nasim; Daniel C Link; Michael H Tomasson; Peter Westervelt; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Matthew J Walter
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

9.  Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.

Authors:  Lijun Shi; Yang Zhang; Lin Feng; Liming Wang; Weiqi Rong; Fan Wu; Jianxiong Wu; Kaitai Zhang; Shujun Cheng
Journal:  Oncotarget       Date:  2017-05-23

10.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

View more
  109 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  Functional TCR T cell screening using single-cell droplet microfluidics.

Authors:  Aude I Segaliny; Guideng Li; Lingshun Kong; Ci Ren; Xiaoming Chen; Jessica K Wang; David Baltimore; Guikai Wu; Weian Zhao
Journal:  Lab Chip       Date:  2018-12-04       Impact factor: 6.799

Review 3.  Personal tumor antigens in blood malignancies: genomics-directed identification and targeting.

Authors:  Livius Penter; Catherine J Wu
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

4.  An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice.

Authors:  Richard F Jones; Joyce D Reyes; Heather M Gibson; Jennifer B Jacob; Ulka Vaishampayan; Stuart Ratner; Kang Chen; Wei-Zen Wei
Journal:  Cancer Immunol Immunother       Date:  2019-06-08       Impact factor: 6.968

5.  Computational and Systems Immunology: A Student's Perspective.

Authors:  Zinaida Good; Jacob Glanville; Marvin H Gee; Mark M Davis; Purvesh Khatri
Journal:  Trends Immunol       Date:  2019-07-06       Impact factor: 16.687

6.  Regulatory T cells subdue an autoimmune disease.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Nature       Date:  2019-08       Impact factor: 49.962

Review 7.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

8.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

Review 9.  Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships.

Authors:  Damian R Plichta; Daniel B Graham; Sathish Subramanian; Ramnik J Xavier
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

10.  T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Authors:  Preeti Sharma; Daniel T Harris; Jennifer D Stone; David M Kranz
Journal:  Cancer Immunol Res       Date:  2019-09-23       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.